Phase II Study of ABI-007 for Gastric Cancer

NCT00661167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: ABI-007

Sponsor

Taiho Pharmaceutical Co., Ltd.